Semaglutide oral drops: what the UK market actually offers

Step 1: Understanding why drops are not a viable delivery route for semaglutide

Semaglutide is a large peptide molecule. In its injectable form it bypasses the digestive system entirely, going straight under the skin. Getting it into the bloodstream via the gut is genuinely difficult, the stomach's acid environment breaks peptides down before they can be absorbed, which is why oral delivery of GLP-1 medicines was considered impractical for decades.

The Wegovy tablet solved this with a co-formulation using sodium N-[8-(2-hydroxybenzoyl) amino] caprylate, known as SNAC. SNAC temporarily raises the local pH around the tablet as it dissolves, creates a brief window in the stomach lining, and allows semaglutide to pass through. It is a tightly engineered mechanism tied to the tablet's physical structure, the rate at which it dissolves, where it dissolves, how much SNAC is present per milligram of semaglutide. A liquid drop preparation cannot replicate that precision. It would dissolve instantly and diffusely, with no localised absorption effect. This is not a regulatory technicality; it reflects basic pharmaceutical reality. No drop formulation of semaglutide has passed clinical trials for weight management, and no such product holds MHRA authorisation. If you have come across products described as semaglutide oral drops, they are either mislabelled, unverified compounds, or counterfeit. The MHRA's Yellow Card reporting scheme exists precisely so that suspect products like these can be flagged and investigated.

Step 2: What the licensed oral option does look like in practice

The MHRA-approved Wegovy tablet made the UK the first country in Europe to license an oral GLP-1 medicine specifically for weight management. The dosing schedule starts at 1.5mg once daily, stepping up through 4mg and 9mg to a 25mg maintenance dose, with at least a month spent at each level. That gradual progression is there for the same reason the injectable version starts slowly: giving the body time to adjust and keeping side effects manageable.

Taking it correctly matters more than with most medicines. The tablet goes first thing in the morning, on a completely empty stomach, with a small amount of plain water, no more than about 120ml. You then wait at least 30 minutes before eating, drinking anything else (including coffee), or taking other oral medicines. Food or liquid disrupts the SNAC absorption window and can reduce how much semaglutide actually gets in. One practical detail worth noting: if your prescription arrives just before a bank holiday or you're away, room-temperature storage means you don't need a cool bag, unlike the injectable pens, which require refrigeration. You can read more about the broader picture of oral semaglutide in the UK, including how it compares to the injection.

Trial evidence from the OASIS 4 study, a 64-week phase 3 trial in 307 adults with obesity or overweight alongside at least one weight-related condition, found an average weight reduction of around 13.6% with the tablet versus roughly 2.4% with placebo. Among participants who stayed fully adherent to their treatment throughout, the figure was closer to 16.6%. These results were published alongside the MHRA approval in June 2026 and are available through GOV.UK's regulatory announcements for context.

Step 3: Who the tablet is actually licensed for, and what a prescriber looks at

The Wegovy tablet is licensed for adults with a BMI of 30 or above, or a BMI of 27 to 29.9 where at least one weight-related condition is present, things like high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnoea. These thresholds follow the same logic as the injectable Wegovy, and lower BMI cutoffs apply for some ethnic backgrounds under UK clinical guidance.

A BMI that meets the numbers is a starting point, not a guarantee. A prescriber reviews the full picture: medical history, current medicines, contraindications, and whether the tablet is the most appropriate option. People who are pregnant, breastfeeding, or actively trying to conceive are not suitable candidates for semaglutide treatment. The same applies to anyone under 18. Certain conditions (including a personal or family history of medullary thyroid carcinoma, or a history of pancreatitis) would also give a prescriber pause. If you want a clearer sense of whether you might be suitable, the semaglutide oral weight loss guide covers eligibility in more depth.

It is also worth knowing what the tablet is not. Rybelsus tablets are also oral semaglutide, but at different strengths (3mg, 7mg, and 14mg) and they are licensed for type 2 diabetes, not weight management. The two products are not interchangeable, and the strength schedules are entirely separate. If you see references to a 14mg or 7mg semaglutide tablet in a weight-loss context, that is a Rybelsus strength being misapplied. The Wegovy tablet schedule runs 1.5mg, 4mg, 9mg, and 25mg only.

Step 4: Getting a legitimate prescription, and what to avoid

Because semaglutide is a prescription-only medicine, every legitimate supply starts with a clinical consultation. There is no route around this. Products marketed as oral semaglutide drops (often appearing through social media adverts or unofficial online marketplaces) almost never involve a prescriber. Some contain no active ingredient at all. Others contain unlicensed compounds at unverified doses. The MHRA has repeatedly warned the public about unlicensed weight-loss products sold online, and reports can be made via the Yellow Card scheme.

A legitimate online pharmacy will be registered with the GPhC. You can verify any pharmacy's registration directly at the GPhC's pharmacy register. At nume, every consultation is reviewed personally by a GPhC-registered Independent Prescriber (not an automated system) before any prescription is issued. Our clinical team oversees every case, and our GPhC premises registration (9012878) is publicly verifiable.

If you would like to explore whether the Wegovy tablet or another licensed treatment might suit you, you can find an overview of the options on our weight loss treatments page, or review the specifics on Wegovy tablets. For questions about cost, the Wegovy tablet pricing page sets out what an all-inclusive private prescription involves. If you are ready to find out whether you qualify, check your eligibility through a free consultation with our prescribers.